Metformin vs Bimatoprost: side-by-side comparison
Metformin (Biguanide) and Bimatoprost (Prostaglandin analogue) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Metformin | Bimatoprost |
|---|---|---|
| Therapeutic class | Biguanide | Prostaglandin analogue |
| CAS | 657-24-9 | 155206-00-1 |
| ATC | A10BA02 | S01EE03 |
| Molecular weight | 129.16 g/mol | 415.57 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Metformin and Bimatoprost share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Metformin acts by a different mechanism than Bimatoprost, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Metformin: Metformin's principal effect is to suppress hepatic glucose production by inhibiting mitochondrial complex I, which raises the cellular AMP/ATP ratio and activates AMP-activated protein kinase. Bimatoprost: Bimatoprost is a prostamide analogue that increases aqueous humour outflow through both the trabecular meshwork and the uveoscleral pathway, lowering intraocular pressure.
Indications compared
Metformin: Metformin is indicated as first-line oral therapy in adults and selected paediatric populations with type 2 diabetes mellitus, alone or in combination with other antidiabetic agents, including insulin. Bimatoprost: Bimatoprost is approved in adults for the treatment of ocular hypertension and chronic open-angle glaucoma.
Safety profile
Metformin: The most common adverse effects are gastrointestinal: nausea, diarrhoea, abdominal discomfort and metallic taste, often improved by gradual titration, food intake or use of the extended-release formulation. Bimatoprost: Common adverse effects include conjunctival hyperaemia, ocular irritation, eyelash growth and darkening, and progressive iris pigmentation, which is permanent.
Frequently asked questions
Is Metformin better than Bimatoprost? ▾
Metformin and Bimatoprost are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Metformin and Bimatoprost be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Metformin
Products with Bimatoprost
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.